Latest minority interest for ECTE: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Echo Therapeutics posts a minority interest of $0 as of September 2016. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Echo Therapeutics's minority interest was $0. The latest reading is $0 (period ending September 2016). Use the history and growth charts on this page for a longer lookback.
Minority Interest is one piece of Echo Therapeutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for ECTE's minority interest usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Echo Therapeutics's other metric pages and overview cover the third.